{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:50:51Z","timestamp":1791946251633,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.radonc.2026.111717","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:15:11Z","timestamp":1785885311000},"page":"111717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-9805","authenticated-orcid":false,"given":"Richard","family":"Canters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-4604","authenticated-orcid":false,"given":"Vlad","family":"Badiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5214-0190","authenticated-orcid":false,"given":"Dominique","family":"Reijtenbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-1554","authenticated-orcid":false,"given":"Esther","family":"Kneepkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5478-9389","authenticated-orcid":false,"given":"Gloria","family":"Vilches-Freixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Berbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111717_b0005","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2019.09.015","article-title":"NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer","volume":"141","author":"Thomas","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2013.04.006","article-title":"Predictors of postoperative complications after trimodality therapy for esophageal cancer NIH public access","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0030","first-page":"605","article-title":"Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients","volume":"21","author":"Bosch","year":"2014","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijrobp.2006.06.002","article-title":"Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"66","author":"Tucker","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/COC.0000000000000573","article-title":"Cardiac toxicity in operable esophageal cancer patients treated with or without chemoradiation","volume":"42","author":"Witt","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0045","first-page":"17","article-title":"Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy","volume":"17","author":"Xu","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0050","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0055","first-page":"516","article-title":"Increased risk of death due to heart disease after radiotherapy for esophageal cancer","volume":"6","author":"Frandsen","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0060","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.07.2001","article-title":"Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study","volume":"81","author":"Welsh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-0966-5","article-title":"Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma","volume":"13","author":"Hirano","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2022.04.029","article-title":"Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight European centres","volume":"172","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111164","article-title":"National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands","volume":"213","author":"Muijs","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0080","article-title":"Adaptive vs. non-adaptive proton therapy in esophageal cancer treatment planning: impact on mean heart dose and post-treatment mortality","volume":"17","author":"Badiu","year":"2025","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2026.111717_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111002","article-title":"Dose to the left ventricle is associated to the risk of acute cardiac toxicity in patients with esophageal cancer undergoing trimodality treatment","volume":"209","author":"Populaire","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2019.09.005","article-title":"Multifactorial risk factors for mortality after chemotherapy and radiotherapy for non-small cell lung cancer","volume":"152","author":"Defraene","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0095","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.21037\/jtd-2019-cptn-06","article-title":"Proton beam radiotherapy for esophagus cancer: State of the art","volume":"12","author":"Gergelis","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2026.111717_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110409","article-title":"Robustness of intensity modulated proton treatment of esophageal cancer for anatomical changes and breathing motion","volume":"198","author":"Canters","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mp.18037","article-title":"Dose accumulation over the treatment course including setup and range uncertainty for proton therapy of esophageal and lung cancer patients","volume":"52","author":"Taasti","year":"2025","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0110","article-title":"Intrafraction motion analysis in online adaptive radiotherapy for esophageal cancer. Phys Imaging","volume":"26","author":"Boekhoff","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2019.04.014","article-title":"Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping","volume":"136","author":"Hoffmann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0120","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3109\/0284186X.2015.1068449","article-title":"Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients","volume":"54","author":"Nyeng","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2026.111717_b0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2021.04.040","article-title":"Strategies for motion robust proton therapy with pencil beam scanning for esophageal cancer","volume":"111","author":"M\u00f8ller","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1118\/1.4940789","article-title":"Motion-robust intensity-modulated proton therapy for distal esophageal cancer","volume":"43","author":"Yu","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0135","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/0284186X.2022.2091949","article-title":"Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer","volume":"61","author":"Shamshad","year":"2022","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2026.111717_b0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2021.09.015","article-title":"Diaphragm-based position verification to improve daily target dose coverage in proton and photon radiation therapy treatment of distal esophageal cancer","volume":"112","author":"Visser","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-025-14504-2","article-title":"Assessment of intra-fractional and inter-fractional motion in esophageal cancer treated with intensity-modulated proton therapy","volume":"25","author":"Fan","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2026.111717_b0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2020.11.032","article-title":"Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer","volume":"156","author":"Thomas","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0155","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1002\/mp.15067","article-title":"Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude","volume":"48","author":"Taasti","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111717_b0160","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2340\/1651-226X.2025.42774","article-title":"Radiotherapy quality assurance in the PROTECT trial-a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer","volume":"2025","author":"Byskov","year":"2025","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2026.111717_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109980","article-title":"Proton versus photon therapy for esophageal cancer \u2013 a trimodality strategy (PROTECT) NCT050555648","volume":"190","author":"Mortensen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2024.14730","article-title":"Predictive model for acute radiation esophagitis in esophageal carcinoma based on prognostic nutritional index and systemic inflammatory index and its application","volume":"28","author":"Wu","year":"2024","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2026.111717_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2015.08.010","article-title":"Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy","volume":"117","author":"Wijsman","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/0284186X.2020.1759819","article-title":"Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI","volume":"59","author":"Defize","year":"2020","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2026.111717_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mco.2024.2717","article-title":"Cardiac volume reduction during radiotherapy in patients with esophageal carcinoma","volume":"20","author":"Makita","year":"2024","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2018.04.008","article-title":"Heart volume reduction during radiotherapy involving the thoracic region in children: an unexplained phenomenon","volume":"128","author":"van Dijk","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/0284186X.2020.1843707","article-title":"A comprehensive motion analysis\u2013consequences for high precision image-guided radiotherapy of esophageal cancer patients","volume":"60","author":"Roos","year":"2021","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2026.111717_b0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jrr\/rrad100","article-title":"The potential overdose of heart and left anterior descending coronary artery region during intensity-modulated radiation therapy in patients with esophageal cancer","volume":"65","author":"Makita","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2026.111717_b0210","first-page":"118","article-title":"O 082 - Implementation of a heart dose based adaptative protocol in proton therapy of esophageal cancer","author":"Canters","year":"2023","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2026.111717_b0215","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0167-8140(23)08516-X","article-title":"OC-0102 Clinical evaluation of heart dose changes during proton therapy of esophageal cancer","volume":"182","author":"Canters","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2026.111717_b0220","first-page":"1","article-title":"Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy","volume":"17","author":"van Kesteren","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.radonc.2026.111717_b0230","article-title":"Identifying the optimal time point for adaptive re-planning in prostate cancer radiotherapy to minimise rectal toxicity using normal tissue imaging biomarkers","volume":"36","author":"Yang","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111717_b0235","first-page":"1","article-title":"A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"}],"updated-by":[{"DOI":"10.1016\/j.radonc.2026.111773","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:34:55Z","timestamp":1790714095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026005566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0167814026005566"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111717","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111717"}}